ArticleCHEST critical care2026
The Use of the Rox Index to Guide High-Flow Nasal Cannula Therapy and the Need for Intubation Is Associated With Meaningful Patient Outcomes.
Article in CHEST critical care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundAcute hypoxemic respiratory failure (AHRF) is a common and life-threatening condition frequently managed with high-flow nasal cannula (HFNC) oxygenation. The ROX index, the ratio of oxygen saturation to FIO RESEARCH QUESTION: What is the impact on outcomes when the ROX index is used to guide decisions-making in the timing of intubation in patients receiving high-flow nasal cannula therapy? STUDY DESIGN AND
methodsA retrospective observational cohort study at an academic medical center emergency department (ED) was undertaken. Two hundred thirty-three adults were initiated on HFNC oxygenation for AHRF between January and December 2022. ROX indices were calculated retrospectively at 4, 6, and 12 hours after HFNC oxygenation initiation. Patients were categorized based on whether their care aligned with ROX predictions as ROX concordant or ROX discordant. The primary outcome was persistent organ dysfunction plus death (POD+D), a composite measure of death and ongoing need for mechanical ventilation, vasopressors, or new dialysis, assessed at day 28.
resultsEighty-two percent of patients (n = 191) received ROX-concordant care, whereas 18% of patients (n = 42) received ROX-discordant care. Despite similar baseline characteristics, patients receiving ROX-discordant care experienced significantly worse outcomes: higher POD+D (62% vs 16%;
interpretationIn patients treated with HFNC oxygenation in the ED, clinical decisions aligned with ROX index predictions were associated with significantly better outcomes. Discordant care, especially premature intubation, correlates with increased morbidity and mortality. These findings support prospective validation of improved outcomes with ROX-concordant actions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.